Exosomal LncRNAs and CircRNAs in lung cancer: Emerging regulators and potential therapeutic targets
Authors:
Open Access
- 1 December 2024
- journal article
- review article
- Published by KEAI Publishing in Non-coding RNA Research
- Vol. 9 (4) , 1069-1079
Abstract
Lung cancer remains one of the most prevalent and lethal malignancies globally, characterized by high incidence and mortality rates among all cancers. The delayed diagnosis of lung cancer at intermediate to advanced stages frequently leads to suboptimal treatment outcomes. To improve the management of this disease, it is imperative to identify new, highly sensitive prognostic and diagnostic biomarkers. Exosomes, extracellular vesicles with a lipid-bilayer structure and a size range of 30-150 nm, are pivotal in intercellular communication and play significant roles in lung cancer progression. Non-coding RNAs (ncRNAs), including long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), are highly prevalent within exosomes and play a crucial role in various pathophysiological processes mediated by these extracellular vesicles. Beyond their established functions in miRNA and protein sequestration, these ncRNAs are involved in regulating translation and interactions within exosomes. Numerous studies have highlighted the importance of exosomal lncRNAs and circRNAs in influencing epithelial-mesenchymal transition (EMT), angiogenesis, proliferation, invasion, migration, and metastasis in lung cancer. Due to their unique functional characteristics, these molecules are promising therapeutic targets and biomarkers for diagnosis and prognosis. This review provides a succinct summary of the formation of exosomal lncRNAs and circRNAs, clarifies their biological roles, and thoroughly explains the mechanisms by which they participate in the progression of lung cancer. Finally, we discuss the potential clinical applications and challenges associated with exosomal lncRNAs and circRNAs in lung cancer.Keywords
This publication has 122 references indexed in Scilit:
- Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancerInternational Journal of Clinical Oncology, 2022
- Exosomal microRNAs and long noncoding RNAs: Novel mediators of drug resistance in lung cancerJournal of Cellular Physiology, 2022
- Emerging role of exosomal long non-coding RNAs in lung cancerMolecular Biology Reports, 2022
- Increased serum exosomal long non‐coding RNA SNHG15 expression predicts poor prognosis in non‐small cell lung cancerJournal of Clinical Laboratory Analysis, 2021
- Tumor‐derived exosomal miR‐19b‐3p facilitates M2 macrophage polarization and exosomal LINC00273 secretion to promote lung adenocarcinoma metastasis via Hippo pathwayClinical and Translational Medicine, 2021
- Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axisMolecular and Cellular Biochemistry, 2021
- Tumor-derived exosomes in the regulation of macrophage polarizationInflammation Research, 2020
- Tumor‐derived exosomal lncRNA GAS5 as a biomarker for early‐stage non‐small‐cell lung cancer diagnosisJournal of Cellular Physiology, 2019
- The circRNA–microRNA code: emerging implications for cancer diagnosis and treatmentMolecular Oncology, 2019
- The functional roles of exosomal long non-coding RNAs in cancerCellular and Molecular Life Sciences, 2019